openPR Logo
Press release

Pharmacogenomics Market Report 2022 : Share, Growth, Trend And Forecast 2031 | Abbott Laboratories, AstraZeneca plc, Bayer AG, Illumina Inc, GlaxoSmithKline plc

12-14-2022 07:23 AM CET | Health & Medicine

Press release from: The Business research company

Pharmacogenomics Market Trends

Pharmacogenomics Market Trends

Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!
https://www.thebusinessresearchcompany.com/opportunities-and-strategies-reports

The global pharmacogenomics market report by the business research company identifies the rising demand for precision medicine is driving to be a major growth driver for the pharmacogenomics market. Precision medicine is a medical model that proposes healthcare customization, with medical decisions, treatments, practices, or products tailored to a subset of patients rather than a one-drug-fits-all model. There is rising demand for precision medicine as it is the most advanced in oncology, having wider, exciting applications beyond oncology and late-stage diseases such as rare and genetic diseases. The main aim of precision medicine is to integrate genetic and environmental information about particular diseases and/or their responses to particular treatments. For instance, according to the article published on Linchpinseo in March 2022, the increasing demand for precision medicine investment from leading pharmaceutical companies is experiencing a 1/3 increase in the next five years. Furthermore, in the USA, 30 million people with type 2 diabetes are diagnosed and treated. Precision medicine provides individualized treatment and will re-calibrate current treatment practices. Hence, the increasing demand for precision medicine will drive the pharmacogenomics market.

The global pharmacogenomics market size is expected to grow from $6.64 billion in 2021 to $7.23 billion in 2022 at a compound annual growth rate (CAGR) of 8.93%. The global pharmacogenomics market size is expected to reach $10.51 billion in 2026 at a compound annual growth rate (CAGR) of 9.80%.

Purchase The Pharmacogenomics Market Report Here:
https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

North America was the largest region in the pharmacogenomics market in 2021. Asia-Pacific is expected to be the fastest-growing region in the global pharmacogenomics market during the forecast period. The regions covered in the global pharmacogenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Major players in the pharmacogenomics market are Abbott Laboratories, AstraZeneca plc, Becton Dickinson and Company, Bayer AG, F Hoffmann-La Roche AG, Illumina Inc, GlaxoSmithKline plc, Merck KGaA, Myriad Genetics Inc, Thermo Fisher Scientific Inc, OPKO Health Inc, Assurex Health Inc, Empire Genomics LLC, Future Science Group, and Pathway Genomics Corporation.

The global pharmacogenomics market is segmented -
1) By Technology: Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Others

2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

3) By Applications: Neurology, Drug Discovery, Oncology, Cardiology, Pain Management, Others

4) By End User: Hospitals and Clinics, Research Institutions, Academic Institutes

Request A Free Sample Of The Pharmacogenomics Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7072&type=smp

The Pharmacogenomics Market Report Contents Include
1. Executive Summary
2. Pharmacogenomics Market Characteristics
3. Pharmacogenomics Market Trends And Strategies
4. Impact Of COVID-19 On Pharmacogenomics
5. Pharmacogenomics Market Size And Growth
....
26. Africa Pharmacogenomics Market
27. Pharmacogenomics Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Pharmacogenomics Market
29. Pharmacogenomics Market Future Outlook and Potential Analysis
30. Appendix

This report covers the trends and market dynamics of the Pharmacogenomics market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Contact Information: 
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check Out Our:
TBRC Blog: http://blog.tbrc.info/
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Healthcare Blog: https://healthcareresearchreports.com/

About Us: 
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacogenomics Market Report 2022 : Share, Growth, Trend And Forecast 2031 | Abbott Laboratories, AstraZeneca plc, Bayer AG, Illumina Inc, GlaxoSmithKline plc here

News-ID: 2847982 • Views:

More Releases from The Business research company

Alcoholic Hepatitis Treatment Market Size, Latest Trends, Growth Rate, Key Drivers And Forecast To 2033
Alcoholic Hepatitis Treatment Market Size, Latest Trends, Growth Rate, Key Drive …
The alcoholic hepatitis treatment market size has grown strongly in recent years. It will grow from $2.95 billion in 2023 to $3.18 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to high prevalence of alcohol abuse, increased awareness and diagnostics, government initiatives on alcoholism, increased healthcare expenditure, public health campaigns. The alcoholic hepatitis treatment market size
Acute Ischemic Stroke Diagnosis Market Analysis, Industry Size, Share, Key Players And Forecast To 2033
Acute Ischemic Stroke Diagnosis Market Analysis, Industry Size, Share, Key Playe …
The acute ischemic stroke diagnosis market size has grown strongly in recent years. It will grow from $2.14 billion in 2023 to $2.31 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rise in cardiovascular risk factors, telemedicine adoption, establishment of stroke centers, increased aging population, development of thrombolytic therapies. The acute ischemic stroke diagnosis market
Peptide Synthesis Market Size, Growth, Market Analysis, Segmentation, And Forecast To 2033
Peptide Synthesis Market Size, Growth, Market Analysis, Segmentation, And Foreca …
The peptide synthesis market size has grown strongly in recent years. It will grow from $5.22 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rise in peptide-based vaccines, growth in biotechnology and biopharmaceuticals, demand for high-purity peptides, regulatory approvals and standardization.. The peptide synthesis market size is expected to see
Acute Bacterial Skin And Skin Structure Infections Market Size, Top Key Players, Growth, Trend Analysis And Forecast To 2033
Acute Bacterial Skin And Skin Structure Infections Market Size, Top Key Players, …
The acute bacterial skin and skin structure infections market size has grown rapidly in recent years. It will grow from $10.57 billion in 2023 to $11.75 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to healthcare industry innovation, economic factors, patient population trends, evolving diagnostic methods, clinical trial innovation.. The acute bacterial skin and skin structure

All 5 Releases


More Releases for Pharmacogenomics

Pharmacogenomics Market Is Booming Worldwide 2022-2028
Another factual information on the ""Pharmacogenomics Market"" has as of late added by CMI to its storehouse. This global research report offers an inside and out examination of various perspectives, for example, global market patterns, pieces of the overall industry, drivers, restrictions, opportunities. It gives an investigative view to settle on further choices in organizations. It covers comprehensive instructive information of various key players working over the globe. Get PDF Brochure
Pharmacogenomics Market || Global Forecast and Analysis 2020-2030
The study of Pharmacogenomics Market published by Prophecy Market Insights offerings all compilation of the historical, current and future outlook of the market. This report is very helpful for understanding the market complexity. This report will help manufacturers, distributors, and retailers to realize and understand the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue etc. Also this
Pharmacogenomics Market Size & Share Expanding Across the Globe
Allied Market Research published a report, titled, "Pharmacogenomics Market by Technology (Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, and Others), Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management, and Others), and End User (Hospitals & Clinics, Research Institutions and Academic Institutes and Others): Opportunity Analysis and Industry Forecast, 2017 – 2025." The report provides a comprehensive analysis of top investment pockets, drivers & opportunities, major
Pharmacogenomics Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Pharmacogenomics Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-paediatric-sports-medicine-market_p104058.html   Pharmacogenomics is the study of the role of the
Pharmacogenomics Market Analysis, Forecast, and Assessment 2025
Pharmacogenomics is the study of inherited variations in human genes that affect an individual’s reaction to a particular drug. It co-integrates genetic science with pharmaceutical science. Hence, it is the science of individualizing a drug based on an individual’s genetic makeup. Pharmacogenomics is also linked to personalized medicine, as environmental conditions, genetic variations, and changing lifestyle greatly influence the type and severity of diseases as well as therapeutic responses that
Pharmacogenomics Market : Share, Analysis To 2025
Pharmacogenomics is the study of inherited variations in human genes that affect an individual’s reaction to a particular drug. It co-integrates genetic science with pharmaceutical science. Hence, it is the science of individualizing a drug based on an individual’s genetic makeup. Pharmacogenomics is also linked to personalized medicine, as environmental conditions, genetic variations, and changing lifestyle greatly influence the type and severity of diseases as well as therapeutic responses that